Prevention is better than cure – with the cutting-edge iPrevent blood test, you gain access to early detection or monitoring of cancer, often at stages where imaging (ultrasound, CT, MRI) still shows no signs.
What Does the iPrevent Test Detect?
The iPrevent test is designed to identify:
Circulating Tumor Cells (CTCs):
These are cancer cells that have detached from a primary tumour (even if it’s too small to be seen by imaging) and entered the bloodstream.
Their presence can be an early indicator of cancer, sometimes months or even years before symptoms appear or tumours are detectable by MRI, CT, or ultrasound.
Early-Stage Cancer Activity:
By identifying CTCs, the test may detect ongoing cancer development in its pre-clinical or microscopic phase.
It offers insight into potential malignancies even in asymptomatic individuals.
Cancer Recurrence Monitoring:
For people previously treated for cancer, the iPrevent test can help monitor for recurrence by picking up CTCs that might signal residual or returning disease.